Fisker Inc./DE: Nasdaq/NYSE listing notice — Fisker receives NYSE delisting warning for stock price below $1.00

Fisker Inc./DE

NYSE notified Fisker on Feb 15, 2024 that average closing price was below $1.00 over 30 consecutive trading days.
Company has a six-month cure period to regain compliance under NYSE Section 802.01C.
Cure requires closing price ≥$1.00 and average ≥$1.00 over 30 trading days by month-end.
Fisker is considering a reverse stock split, subject to stockholder approval at next annual meeting.
Stock continues to trade on NYSE under symbol FSR during the cure period.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Fisker Inc./DE received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

February 15, 2024, Fisker Inc. (the “Company,” “we,” “us” or “our”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s common stock from the NYSE. Pursuant to Section 802.01C, the Company has a period of six months from receipt of the notice to regain compliance with the minimum stock price listing requirement.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-24-038568

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.